drugset / Trial / NCT02989493
Testing Doxazosin to Treat Stress Mechanisms in Alcoholism
Phase 2
Completed
61 enrolled
University of Wisconsin, Madison
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Double-blind, placebo controlled, randomized controlled trial (RCT) for Alcohol Use Disorder examining the effects of doxazosin, a norepinephrine alpha1 receptor antagonist, on stress reactivity and clinical outcomes.
Timeline
- Start
- 2017-04-12
- Primary completion
- 2020-03-13
- Completion
- 2020-03-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxazosin | Small molecule | 8 mg | — |